Filter
1458
Text search:
medicamentos
Featured
96
299
Language
Document type
668
365
149
91
75
44
27
11
10
9
6
3
Countries
107
102
82
72
63
62
59
37
35
32
30
29
27
26
24
24
22
22
20
20
17
17
17
15
13
13
13
13
12
12
12
12
9
9
9
8
8
7
7
6
6
6
6
6
6
5
5
5
5
5
4
4
4
4
4
4
4
4
3
3
3
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
955
79
36
25
16
13
5
3
Toolboxes
243
165
122
80
54
35
28
25
22
21
15
15
10
9
9
7
6
5
3
3
1
Regulation of the President of the Republic of Indonesia on the Implementation of Patents by the Government on Antiviral and Antiretroviral Drugs
National Policy on HIV and AIDS Response through Reduction of Adverse Effects of the Usage of Injecting Narcotics, Psychotropics and other addictive Substances
Government Regulation of the Republic of Indonesia regarding Security of Pharmaceutical Preparations and Medical Equipments
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
Ethiopia Antimicrobial Resistance Surveillance Plan
This CPD Policy relates to all health professionals in the four Health Professional Councils in Rwanda namely; RMDC, NCNM, RAHPC, and RPC. The policy requires all health professionals to participate in the CPD Programs. The purpose of this CPD Policy is to support the professionals in the respective
...
Accessed August 31,2017
Accessed August, 2017
Afr J Tradit Complement Altern Med. (2016) 13(4):123-131
Out of 400 questionnaires distributed to the participants, 389 were returned with data acceptable for analysis. Ages of the participants ranged from 18 to 75 years (Mean=43 + 11.6). Out of the 272 (69.9%) participants who conceded that th ...
Out of 400 questionnaires distributed to the participants, 389 were returned with data acceptable for analysis. Ages of the participants ranged from 18 to 75 years (Mean=43 + 11.6). Out of the 272 (69.9%) participants who conceded that th ...
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products to help in the continuous safety monitoring of products granted marketing authorization in Ghana.
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
PMPB/INS-GUIDE/01
PMPB/INS-GUIDE/04
